16:15 – 17:45 …… Navigating Keratoconus Treatment: A Tapestry of Therapeutic Strategies- Part 2
Chairperson: Adel Barbara
Panelists: Berthold Seitz, Cosimo Mazzotta, Rohit Shetty
16:15 | Multicenter, randomized, double-masked, sham-controlled, parallel-group phase 3 FDA study to evaluate the efficacy and safety of epithelium-on corneal cross-linking in subjects 8 to 45 years of age with keratoconus |
16:23 | Toric ICL in keratoconus, mystery cases |
16:31 | Long term stability of intracorneal ring segment implantation followed by same-day topography-guided PRK and crosslinking. |
16:39 | Phakic ICLs for keratoconus correction (20 Years’ Experience) |
16:47 | Adapting and applying Sub400 protocol with Accelerated Corneal Crosslinking ( ACXL) device (9mW /cm2 - continuouslight UV irradiation) |
16:55 | Minimal invasive topography guided photorefractive keratectomy with custom cross linking (MITCX) |
17:03 | The M nonomgram: Tackling the route of the standardized treatment of thin ectatic corneas |
17:11 | Combined treatments for refractive tuning in keratoconus: Phakic IOLs |
17:19 | A novel technique for porcine corneal lenticular implantation in patients with advanced keratoconus |
17:27 | Corneal remodeling with progressive thickness ICR segments |
17:35 | Customised peripheral corneal cross-linking (P-CXL) for ultrathin corneas with stage 3 and 4 keratoconus: A novel alternative to more invasive surgery. |
17:43 | Discussion |